Il‐Kyoo Park

534 total citations
10 papers, 420 citations indexed

About

Il‐Kyoo Park is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Il‐Kyoo Park has authored 10 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Il‐Kyoo Park's work include Phagocytosis and Immune Regulation (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Il‐Kyoo Park is often cited by papers focused on Phagocytosis and Immune Regulation (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Il‐Kyoo Park collaborates with scholars based in United States, South Korea and France. Il‐Kyoo Park's co-authors include Michael A. Caligiuri, Rossana Trotta, Jianhua Yu, Guido Marcucci, Tiffany Hughes, Susan McClory, Jianying Zhang, Wei Min, Shu‐Jun Liu and Hsiaoyin Mao and has published in prestigious journals such as Blood, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Il‐Kyoo Park

10 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Il‐Kyoo Park United States 7 297 95 94 90 39 10 420
Andrew Podd United States 7 304 1.0× 85 0.9× 73 0.8× 54 0.6× 75 1.9× 10 434
Iwona Konieczna United States 8 279 0.9× 108 1.1× 92 1.0× 86 1.0× 16 0.4× 13 501
Simanta Pathak United States 9 210 0.7× 86 0.9× 121 1.3× 62 0.7× 30 0.8× 12 371
Arnaud Villacreces France 11 194 0.7× 73 0.8× 145 1.5× 172 1.9× 60 1.5× 18 415
Donald Gravenor United States 9 174 0.6× 214 2.3× 150 1.6× 98 1.1× 50 1.3× 24 433
Mizuha Kosugi‐Kanaya Japan 8 203 0.7× 85 0.9× 75 0.8× 62 0.7× 10 0.3× 14 324
Alexander Henke Germany 7 159 0.5× 83 0.9× 130 1.4× 20 0.2× 36 0.9× 9 393
Darlene Monlish United States 11 228 0.8× 68 0.7× 135 1.4× 116 1.3× 29 0.7× 25 387
Nobuyoshi Hanaoka Japan 6 110 0.4× 69 0.7× 103 1.1× 76 0.8× 22 0.6× 26 276
Nona Shayegi Germany 8 154 0.5× 69 0.7× 69 0.7× 226 2.5× 49 1.3× 10 366

Countries citing papers authored by Il‐Kyoo Park

Since Specialization
Citations

This map shows the geographic impact of Il‐Kyoo Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Il‐Kyoo Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Il‐Kyoo Park more than expected).

Fields of papers citing papers by Il‐Kyoo Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Il‐Kyoo Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Il‐Kyoo Park. The network helps show where Il‐Kyoo Park may publish in the future.

Co-authorship network of co-authors of Il‐Kyoo Park

This figure shows the co-authorship network connecting the top 25 collaborators of Il‐Kyoo Park. A scholar is included among the top collaborators of Il‐Kyoo Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Il‐Kyoo Park. Il‐Kyoo Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Park, Il‐Kyoo, Daelynn R. Buelow, Clifford J. Whatcott, et al.. (2017). TP-0903, a Novel Axl Inhibitor with Activity in Drug Resistant FLT3-ITD+ AML through a Mechanism That Includes FLT3 Inhibition. Blood. 130. 2522–2522. 1 indexed citations
2.
Park, Il‐Kyoo, Bethany L. Mundy-Bosse, Steven L. Warner, et al.. (2014). The Receptor Tyrosine Kinase Axl Is Required for Resistance to FLT3-Targeted Therapy in Acute Myeloid Leukemia. Blood. 124(21). 2350–2350. 1 indexed citations
3.
Park, Il‐Kyoo, et al.. (2014). Sunroof Buffeting Simulation of a Simplified Car Model using PAM-FLOW. Transactions of the Korean Society for Noise and Vibration Engineering. 24(3). 198–204. 1 indexed citations
4.
Park, Il‐Kyoo, Rossana Trotta, Jianhua Yu, & Michael A. Caligiuri. (2013). Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell development. European Journal of Immunology. 43(10). 2750–2755. 20 indexed citations
6.
Yu, Jianhua, Hsiaoyin Mao, Wei Min, et al.. (2009). CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood. 115(2). 274–281. 184 indexed citations
7.
Park, Il‐Kyoo, Chiara Giovenzana, Tiffany Hughes, et al.. (2008). The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood. 113(11). 2470–2477. 57 indexed citations
8.
Rudner, Lynnie A., Jack T. Lin, Il‐Kyoo Park, et al.. (2003). Necroinflammatory Liver Disease in BALB/c Background, TGF-β1-Deficient Mice Requires CD4+ T Cells. The Journal of Immunology. 170(9). 4785–4792. 34 indexed citations
9.
Park, Il‐Kyoo, et al.. (2000). Sp1 mediates constitutive and transforming growth factor β-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1490(3). 302–310. 14 indexed citations
10.
Park, Il‐Kyoo, et al.. (1997). Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity. International Journal of Cancer. 71(5). 867–873. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026